Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Patent covering second-generation taxanes issues to Xechem

Jan. 29, 1999

Proteasome inhibitors may have potential in refractory CLL

Jan. 29, 1999

Temodal receives E.U. approval for recurrent gliobastoma multiforme

Jan. 29, 1999

Newly patented antiproliferative agents selectively inhibit protein farnesyltransferase

Jan. 29, 1999

Structurally novel dimeric steroid with cytotoxic activity isolated from marine sponge

Jan. 28, 1999

Orally active inhibitors of tumor neovascularization described by Mercian

Jan. 28, 1999

Ilex, Lilly sign agreement for novel antitumor diarylsulfonylurea

Jan. 27, 1999

Bicalutamide introduced in Argentina by Raffo

Jan. 27, 1999

Canadian pharmaceutical and academic research team discovers new benzoporphyrins for PDT

Jan. 27, 1999

Iron chelator enhances ALA PDT efficacy in rat colon

Jan. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...